JP Morgan Healthcare Conference
Pierian, Seven Bridges, UgenTec Acquired, Merged to Become Velsera
The three firms were acquired by investment fund Summa Equity and merged to form a new Boston-headquartered company.
Element Biosciences Points to First Wave of Customer Data at JP Morgan Conference
The San Diego-based sequencing instrument maker highlighted data from three customers: the University of California, San Diego; Gencove; and Qiagen.
JP Morgan Healthcare Conference, Day 4: Singular Genomics, Quantum-Si, Quanterix
On the last day of the conference, Singular Genomics and Quantum-Si provided updates on their recently launched systems while Quanterix addressed its ongoing restructuring.
Rebranded GeneDx Bets Future on Whole-Exome, Whole-Genome Sequencing in Pediatric Rare Disease
Premium
After dropping underdeveloped Sema4 business lines but emphasizing the Centrellis informatics platform, the new GeneDx expects to reach profitability by 2025.
SomaLogic Seeks 'Strategic Alternatives' for Dx Business to Focus on Life Science Market
The proteomics firm is in talks to either spin off its SomaSignal assays unit or to partner with another company to boost its diagnostics efforts.